Experimental and clinical studies have found that the high-mobility group box-1 (HMGB1), recently discovered damage-associated molecular patterns (DAMPs), is substantially enriched in patients with hepatic fibrosis [13, 14]. This evidence concerns the gene HMGB1 and Hepatic fibrosis.